Bill overview
HB 400 (2026 Session, Kentucky) aims to address fertility treatment through new state-level provisions. The bill has been introduced and referred to committees, with initial committee activity noted in January 2026.
Purpose and intent
- Establishes framework for regulation and/or support of fertility treatment within Kentucky.
- Seeks to clarify rights, responsibilities, and processes related to fertility services, reproductive technologies, and related procedures.
- May address ethical, legal, and practical considerations surrounding fertility treatment, including protections for patients and providers.
Key provisions and changes (provisional summary)
Given the available action history, the bill’s specific text is not provided here. The following describes the typical areas such bills cover. If enacted, HB 400 could include provisions such as:
- Regulation of fertility clinics and practitioners (licensing requirements, standards of care, patient safety protocols).
- Privacy and data handling related to fertility treatments (record-keeping, consent, and confidentiality).
- Financial aspects (insurance coverage, cost transparency, or state-supported funding mechanisms for certain procedures).
- Patient protections (informed consent processes, restrictions on certain practices, and protections for minors or vulnerable individuals).
- Limitations or prohibitions (bans or restrictions on specific technologies or procedures, if any are proposed).
- Availment of state resources (guidance, oversight, or reporting requirements to a state agency).
Note: The exact provisions would be in the bill text. The above reflects common themes in fertility-treatment legislation and may not capture all specifics of HB 400.
Affected parties
- Patients and prospective recipients of fertility treatments (e.g., in vitro fertilization, donor services, genetic testing).
- Fertility clinics, physicians, and other healthcare providers offering reproductive services.
- Health insurers and payers, if the bill addresses coverage or cost transparency.
- State regulatory or oversight agencies responsible for health care licensing and patient safety.
- Potentially family-law or guardianship considerations if the bill touches on consent and decision-making for minors or incapacitated individuals.
Procedural and timeline aspects
- Action history indicates:
- Introduced in the Kentucky House of Representatives on January 15, 2026.
- Referred to the Committee on Committees (H) on January 15, 2026.
- Placed in Judiciary committee (H) on January 23, 2026.
- Next steps typically include hearings, possible amendments, and votes in the pertinent committees, followed by floor consideration if advanced.
Potential impact considerations
- Access: Depending on licensing, funding, and coverage changes, the bill could affect access to fertility services for residents.
- Consumer protections: Any requirements around informed consent, patient safety, and transparency could improve protections for patients.
- Costs: Insurance coverage mandates or cost-reporting requirements could influence out-of-pocket expenses for patients and price structures for providers.
- Legal clarity: Clear statutes governing fertility procedures can reduce ambiguity for clinicians and patients, including consent, records, and cross-border or donor-related issues.
If you would like, I can tailor this summary further once the full text of HB 400 is available, specifying exact sections, definitions, and operative provisions.
